Avantor, Inc. AVTR
AVTR Rating
AVTR Rating Factors
AVTR Company Overview
Avantor, Inc. (NYSE: AVTR) is a global provider of products, services, and solutions that support customers in the life sciences, advanced technologies, and applied materials industries. The company supplies mission-critical materials, laboratory products, bioprocessing technologies, and production services used across research, development, and manufacturing workflows. Avantor’s operations are closely tied to pharmaceutical and biotechnology manufacturing, healthcare, academic research, semiconductor production, and industrial applications. Its business model combines proprietary products with third-party distribution and value-added services, creating recurring demand from highly regulated and research-intensive industries.
The company’s primary revenue drivers include laboratory consumables, biopharma production materials, chemicals, reagents, cleanroom products, and integrated supply-chain services. Avantor is known for its broad product portfolio and global logistics infrastructure, which support large pharmaceutical manufacturers and research institutions. The company traces its roots to the early 20th century through the J.T. Baker chemical business and later evolved through mergers, acquisitions, and private equity ownership before becoming Avantor. A major transformation occurred through the acquisition of VWR Corporation, which significantly expanded its laboratory distribution and global customer reach. Avantor subsequently became a publicly traded company through its 2019 initial public offering.
AVTR Income Statement
AVTR Balance Sheet
AVTR Price History
AVTR Valuation
AVTR Dividends and Shares
AVTR Corporate Info
Building One
Suite 200
100 Matsonford Road
Radnor, PA 19087